School of Clinical Oncology Final (1).pn

panel of consultants


Dr Daniel Tan

Dr Daniel Tan is medical director and senior radiation oncologist at Asian American Radiation & Oncology (AARO). His clinical interests are in the management of central nervous system tumors, prostate and breast cancers. He graduated from the National University of Singapore (NUS) and went on to obtain the Fellowship of the Royal College of Radiologists (FRCR) in Clinical Oncology.

His sub-specialty training was focused on neurooncology, including Proton Therapy at University of Pennsylvania’s Roberts Proton Therapy Center, Spine Radiosurgery at Princess Margaret Hospital and Sunnybrook’s Odette Cancer Centre, and Advanced Radiation Technologies at Tokyo Metropolitan Komagome Hospital.

Dr Tan was national project coordinator for the IAEA’s healthcare project 6065 to train and develop SBRT in countries within the Asia-Pacific and was course director for its first regional training course in 2012. In NCCS, he held the appointments of co-chairperson of the Neuro-Oncology Cancer Service Line Development workgroup as well as clinical lecturer at the Yong Loo Lin School of Medicine at NUS. Dr Tan served as executive committee member of the Singapore Radiological Society and is council member of the College of Radiology Singapore. He earned an MBA in Healthcare Management from NUS business school and has helped to develop several private cancer centers locally and abroad.


Dr David Tan


Dr David Tan is a radiation oncologist at Asian American Radiation & Oncology (AARO). His clinical expertise is in stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) and brachytherapy; and his subspecialty interest is in the management of Gynaecological, Gastrointestinal, and Lung cancers. 

Dr Tan underwent his HMDP fellowship in the UK from 2011 to 2013 where he honed his stereotactic and subspecialty expertise at the Mount Vernon Cancer Centre in Middlesex. There, he trained under renowned experts in the field including Professor Peter Hoskin and Dr Robert Glynne-Jones. He also trained at the Cyberknife Centre where he actively participated in weekly multidisciplinary meetings, and in the enrolment and management of patients in clinical trials. 

Prior to joining AARO, Dr Tan was a consultant at the National Cancer Centre Singapore, where he served for 10 years and pioneered the liver and pancreas SBRT programmes. He was also previously adjunct assistant professor at the Duke-NUS Graduate Medical School and a clinical lecturer at the Nanyang Polytechnic School of Radiation Therapy.


Dr Jonathan Teh


Dr Jonathan Teh is presently a Consultant Radiation Oncologist at Asian American Radiation & Oncology. Prior to that he was an attending at the Division of Radiation Oncology, National Cancer Centre Singapore (NCCS) from 2012 – 2017. He started his Radiation Oncology residency at the NCCS in 2007 and received the Singhealth Health Manpower Development Programme award for advanced training in clinical oncology in 2009. He was an Honorary Clinical Fellow in the Oncology department of the University College London Hospital from 2009 – 2011.  


During this time, he received broad based training in radiotherapy and chemotherapy for various tumour subsites, with particular focus on genitourinary, gastrointestinal and sarcoma oncology. He was conferred the Fellowship of the Royal College of Radiologists, UK, under the chapter of Clinical Oncology in 2011. His current clinical subspecialty interests include genitourinary, gastrointestinal, head and neck, sarcoma and paediatric radiotherapy.   


His research interests include advanced radiotherapy techniques in prostate cancer and he was the Principal Investigator of a Phase II Trial in Stereotactic Body Radiotherapy for localised prostate cancer from 2013 – 2017. 

Dr Jonathan Teh.jpg